Convertible Note Funded Startups in United Kingdom
Convertible note rounds in this UK snapshot are led by BBOXX’s disclosed $15M on 2022-05-12, with the next-largest disclosed amounts at $4M (AGORA, 2022-09…
Convertible note rounds in this UK snapshot are led by BBOXX’s disclosed $15M on 2022-05-12, with the next-largest disclosed amounts at $4M (AGORA, 2022-09-12) and $3M (Oxford Drug Design, 2022-05-19; DirectID, 2022-01-24). Most disclosed rounds cluster much lower (e.g., $3M and below), while one disclosed floor appears at Yanda’s $100K on 2022-03-03.
Geographically, London accounts for the majority of entries (Insly 2022-09-14, AGORA 2022-09-12, The Vurger Co. 2022-05-20, BBOXX 2022-05-12, and Yanda 2022-03-03), with additional cities represented by single entries in Cambridge (Healthera, 2022-07-07), Oxford (Oxford Drug Design, 2022-05-19), Edinburgh (DirectID 2022-01-24; Roslin Technologies 2021-07-15), and more. Temporally, the 12 rows span from 2021-07-15 (Roslin Technologies) to 2022-09-14 (Insly), with several dated between May and July 2022 (BBOXX, Oxford Drug Design, The Vurger Co., and Healthera).
Most recent rounds
12 shownRelated listings
Frequently asked
What’s the largest disclosed convertible note in this UK set, and how far above the rest is it?
BBOXX’s disclosed $15M on 2022-05-12 is the top figure; the next-largest disclosed amounts are $4M (AGORA, 2022-09-12) and $3M (Oxford Drug Design on 2022-05-19; DirectID on 2022-01-24), so the leader materially exceeds the rest of the disclosed range.
How concentrated are the deals by city, and does London dominate?
London holds 5 of 12 entries: Insly (2022-09-14, $1M), AGORA (2022-09-12, $4M), The Vurger Co. (2022-05-20, $2M), BBOXX (2022-05-12, $15M), and Yanda (2022-03-03, $100K). Other locations appear once each, such as Cambridge (Healthera, 2022-07-07, undisclosed) and Oxford (Oxford Drug Design, 2022-05-19, $3M).
Are there any tight time windows where multiple convertible-note rounds land?
Yes. Between 2022-05-12 and 2022-05-20, three disclosed rounds appear in close succession: BBOXX ($15M, 2022-05-12), Oxford Drug Design ($3M, 2022-05-19), and The Vurger Co. ($2M, 2022-05-20). This sits near additional mid-2022 entries like Healthera (2022-07-07, undisclosed) and Ondato (2022-08-01, undisclosed).
What share of the rounds in this list are disclosed versus undisclosed amounts?
In these 12 rows, 8 have disclosed convertible-note amounts (e.g., BBOXX $15M on 2022-05-12; Yanda $100K on 2022-03-03) while 4 are marked undisclosed (Ondato 2022-08-01; Healthera 2022-07-07; plus two additional undisclosed entries). The largest comparisons above rely only on the disclosed amounts.
Which outliers are most likely to be worth deeper diligence?
On the low end, Yanda’s disclosed $100K on 2022-03-03 is far below other disclosed figures (the next-lowest disclosed amount is $1M for Insly on 2022-09-14). On the high end, BBOXX’s $15M on 2022-05-12 is an outlier relative to the $3M–$4M cluster (Oxford Drug Design 2022-05-19, $3M; DirectID 2022-01-24, $3M; AGORA 2022-09-12, $4M).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.